• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medications during breastfeeding and pregnancy is challenging for women with the condition. There aren't enough data on how exposure to adhd medication without prescribing for a long time could affect a pregnant fetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders like hearing loss or vision, febrile seizures or IQ impairment. The authors acknowledge the need for more high-quality studies.

Risk/Benefit Analysis

Women who are pregnant and taking adhd medication and pregnancy uk medications need to balance the advantages of taking them against the potential risks to the foetus. Physicians don't have the necessary data to give clear guidelines but they can provide information on the risks and benefits to aid pregnant women in making informed choices.

A study published in Molecular Psychiatry found that women who used ADHD medications in early pregnancy did not face a significantly increased risk of fetal heart malformations or major birth defects that are structural. Researchers conducted a large population-based case-control study to assess the risk of major structural birth defects in infants born to mothers who had taken stimulants in early pregnancy and those who had not. Clinical geneticists and pediatric cardiologists examined the cases to ensure an accurate case classification and to limit the possibility of bias.

However, the study had its limitations. The researchers were not able, in the first place to differentiate the effects of the medication from the disorder. This limitation makes it difficult for researchers to determine whether the few associations observed between the groups that were exposed to the use of medications or if they were caused by the presence of comorbidities. The researchers also did not examine the long-term effects for the offspring.

The study did reveal that babies whose mothers had taken ADHD medication during pregnancy were at a slightly more risk of being admitted to the neonatal intensive care unit (NICU) than those who were born without any medication or cut back on their medications prior to or during pregnancy. This increase was caused by central nervous system disorders. The increased risk of admission was not affected by the stimulant medication used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher chance of having to have a caesarean section or one whose baby scored low on the Apgar scale (less than 7). These increases appeared to be independent of the type of medication used during pregnancy.

The research suggests that the risk of a small amount with the use of ADHD medications during the early stages of pregnancy may be offset by the higher benefit to both mother and child of continuing treatment for the woman's disorder. Physicians should talk to their patients about this and as much as possible, assist them develop coping strategies that can lessen the effects of her disorder on her daily functioning and her relationships.

Medication Interactions

Many doctors are faced with the decision of whether to maintain treatment or stop during pregnancy as more women are diagnosed with ADHD. These decisions are usually taken without clear and authoritative evidence. Instead, doctors have to weigh their own knowledge, the experience of other doctors, and the research that has been conducted on the subject.

The issue of risk to infants is extremely difficult. The research on this subject is based on observation rather than controlled studies and the results are in conflict. The majority of studies focus on live-births, which could underestimate the teratogenic impact that can lead to abortions or terminations of pregnancy. The study that is discussed in the journal club addresses these limitations, by examining both data on live and deceased births.

The conclusion is that while some studies have shown that there is a positive correlation between ADHD medications and the possibility of certain birth defects, others have found no connection and the majority of studies have a neutral or slightly negative effect. In all cases it is imperative to conduct a thorough evaluation of the risks and benefits should be conducted.

For many women with ADHD and ADD, the decision to stop taking medication is difficult if not impossible. In a recent article in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of loneliness. A loss of medication may also affect the ability to safely drive and to perform work-related tasks which are vital aspects of normal life for those suffering from ADHD.

She suggests that women who are unsure about whether to continue or stop taking medication because of their pregnancy, consider educating family members, friends and colleagues about the condition, its effects on daily functioning, and the advantages of continuing the current treatment regimen. In addition, educating them can make the woman feel more comfortable when she is struggling with her decision. Some medications can pass through the placenta. If the patient decides to stop taking her ADHD medication while breastfeeding, it's important to be aware that the medication could be transferred to the baby.

Birth Defects and Risk of

As the use and abuse of ADHD medication to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases, so does concern about the possible effects of the drugs on foetuses. A study that was published in the journal Molecular Psychiatry adds to the body of knowledge about this subject. Utilizing two huge data sets researchers were able examine more than 4.3 million pregnancies to determine whether the use of stimulant medications increased the risk of birth defects. Although the risk overall remains low, the scientists did find that first-trimester exposure to ADHD medications was linked to a slightly higher rate of certain heart defects, such as ventriculo-septal defect (VSD).

The researchers behind the study found no association between the use of early medications and other congenital anomalies, like facial clefting, or club foot. The results are in line with previous studies showing a small but significant increase in the risk of heart malformations among women who started taking ADHD medications prior to the time of pregnancy. The risk grew in the latter half of pregnancy, as many women decide to stop taking their ADHD medication.

Women who took ADHD medication in the first trimester of their pregnancies were also more likely to experience caesarean sections, a low Apgar score following delivery, and a baby that required breathing assistance during birth. The authors of the study were not able to eliminate selection bias because they limited their study to women who did not have any other medical conditions that might have contributed to the findings.

Researchers hope that their research will inform physicians when they see pregnant women. The researchers advise that while discussing the risks and benefits are important, the choice regarding whether or not to stop medication should be according to the severity of each woman's ADHD symptoms and the needs of the woman.

The authors also warn that while discontinuing the medications is an alternative, it is not an option to consider due to the high incidence of depression and other mental health issues for women who are expecting or recently postpartum. Additionally, research suggests that women who stop taking their medications will have a tough transitioning to life without them after the baby is born.

Nursing

The responsibilities of a new mother can be overwhelming. Women with ADHD who have to manage their symptoms while attending physician appointments as well as making preparations for the arrival of a baby and getting used to new routines at home may face a lot of challenges. Therefore, many women decide to continue taking their intuitive adhd medication medications throughout pregnancy.

The majority of stimulant medicines pass through breast milk in very small quantities, so the risk to the breastfeeding infant is minimal. However, the rate of exposure to medications by the newborn may differ based on dosage, how often it is taken and the time of the day it is administered. In addition, various drugs enter the infant's system via the gastrointestinal tract or through breast milk. The impact on the health of a newborn is not completely known.

Due to the absence of research, some physicians may recommend stopping stimulant drugs during the pregnancy of a woman. This is a difficult choice for the patient, who must weigh the benefit of continuing her medication against the potential dangers to the embryo. Until more information is available, doctors should inquire with all pregnant patients about their experience with ADHD and if they are taking or planning to take medication during the perinatal period.

Numerous studies have proven that women can continue to take their ADHD medication without risk during pregnancy and while breast-feeding. This has led to many patients opt to do this and, in consultation with their doctor they have discovered that the benefits of keeping their current medication outweigh any potential risks.

It's important for women with Adhd Medication And Pregnancy who are considering breastfeeding to seek out a specialist psychiatrist's guidance prior to becoming pregnant. They should discuss their medication with their prescriber as well as the pros and cons for continuing treatment. This includes non-pharmacological methods. Psychoeducation is also needed to help pregnant women suffering from cheapest adhd medication recognize the signs and the underlying disorder. They should also be educated about treatment options and build the coping mechanisms. This should be a multidisciplinary approach, which includes the GP doctors, obstetricians and psychiatrists. Counselling for pregnancy should include discussion of a management plan for both the mother and child, monitoring for signs of deterioration, and the need for adjustments to the medication regimen.